Cefepime vs. Ceftriaxone to Treat Nursing Home-Acquired Pneumonia
Status:
Completed
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
Randomized trial of nursing home residents with pneumonia to assess if intramuscular cefepime
is a safe, efficacious, and cost-effective alternative to once daily intramuscular
ceftriaxone for the treatment of elderly nursing home residents who develop pneumonia and do
not require hospitalization.